PROGNOSIS AND RISK ASSESSMENT IN PATIENTS SUFFERING FROM HEART FAILURE BY DETERMINING THE LEVEL OF ADM AND BNP

MIF AGONISTS AND ANTAGONIST AND THERAPEUTIC USES THEREOF

Methods for Treatment and Diagnosis of Pulmonary Diseases Based on the Expression of SERCA2 Protein

Biochemical markers for acute pulmonary embolism

Methods for treating and diagnosing fibrotic and fibroproliferative diseases

Screening methods for transfusion related acute lung injury (TRALI)

DIAGNOSIS OF PULMONARY AND/OR CARDIOVASCULAR DISEASE

Procalcitonin-based diagnosis of infections or inflammatory diseases of the respiratory tract in a patient with heart failure

Diagnosis and risk stratification by determining the marker CT-proADM

Anti-HIMF antibodies to treat lung diseases

Method to detect virus related immunological markers for the diagnosis of respiratory tract infections

Use of at least one isoform of progesterone receptor membrane component 1 (PGRMC1)

ATTENUATION OF HYPOXIA INDUCED CARDIOVASCULAR DISORDERS

RAPID DETECTION OF VOLATILE ORGANIC COMPOUNDS FOR IDENTIFICATION OF BACTERIA IN A SAMPLE

COMPOSITIONS, KITS AND METHODS FOR DETERMINING ETIOLOGY OF TRALI AND DETECTING PATIENTS AT RISK FOR THIS TRANSFUSION REACTION

RAPID DETECTION OF VOLATILE ORGANIC COMPOUNDS FOR IDENTIFICATION OF BACTERIA IN A SAMPLE

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE

Use of VEGF-D in the diagnosis of lymphangioleiomyomatosis (LAM) disease

Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof

Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)

ANTIFIBROTIC THERAPY

Method for determining the stage of ulcerative colitis or interstitial pneumonitis and reagent kit thereof

Methods for differentiation between cardiac and pulmonary causes of chronic dyspnea

Method for detecting mycobacterial infection

Methods and Compositions for Mycoplasma Toxins

Biochemical markers for acute pulmonary embolism

Method of treating fibrosis in a subject in need thereof comprising administering a composition comprising a CSD

Artificial tissue constructs comprising alveolar cells and methods for using the same

METHOD OF IDENTIFYING PROTEINS IN HUMAN SERUM INDICATIVE OF PATHOLOGIES OF HUMAN LUNG TISSUES

Immunological assay for plasmin-digested products of stabilized fibrin

Phosphorylated or Non-Phosphorylated MPR as Diagnostic Marker or Therapeutic Target

Molecules for the treatment of lung disease involving an immune reaction to connective tissue found in the lung

TB diagnostics based on mycobacterium tuberculosis excretory secretory antigens and their specific immunoglobulins

Anti-αβantibodies and uses thereof

Diagnostic and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Alpha (Ppara)

VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE(CIRD)

Methods and Systems for Treating Asthma and Other Respiratory Diseases

Composition for Prevention, Treatment, and Diagnosis of Chronic Inflammatory Airway Diseases

Cellular antagonists of GPCR physiology

Differentiation of cardiac and pulmonary causes of acute shortness of breath

Apparatus and method for detecting lung cancer using exhaled breath

Method of diagnosing infectious disease by measuring the level of soluble TREM-1 in a sample

Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3

Predicting mortality and detecting severe disease

Recombinant 12-KDA protein useful for the detection of respiratory allergies

Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof

Hedgehog Kinases and Their Use in Modulating Hedgehog Signaling

Cell division marker

Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)

Methods of treating idiopathic pulmonary fibrosis

Tuberculosis antigen detection assays and vaccines

Phospholipid formulations and uses thereof in lung disease detection and treatment

RelA-ASSOCIATED INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF

Method for analyzing biological data sets

PGE-M as a biomarker of pulmonary inflammation

Methods and compositions for beryllium-induced Disease

Sialic acid permease system

Use of IL-17F in diagnosis and therapy of airway inflammation

Method for characterizing the efficacy of an agent targeting a primary cystic fibrosis defect

Diagnosis of conditions associated with decreased arginine bioavailability

Method of potentiating inflammatory and immune modulation for cell and drug therapy

Use of parathyroid hormone-related protein (PTHrP) in the diagnosis and treatment of chronic lung disease and other pathologies

Diagnosis of disease and monitoring of therapy using gene expression analysis of peripheral blood cells

Methods and compositions for using aleveolar macrophage phospholipase A2

Methods and compositions for using alveolar macrophage phospholipase A2

Assays for detecting pathogenic respiratory bacteria

Use of parathyroid hormone-related protein(PTHRP) in the diagnosis and treatment of chronic lung disease and other pathologies

Use of free hemoglobin and its surrogate markers to detect and monitor pulmonary hypertension

Method for assessment of cystic lung fibrosis